If you suspect hormones may be playing a role, speak to your doctor for appropriate tests and management options
Most cases of MIS-C associated with COVID-19 are treated following the standard protocols for Kawasaki disease ( MIS-C is a severe condition similar to Kawasaki disease, based on six main diagnostic elements: pediatric age, persistent fever, presence of laboratory markers of inflammation, signs or symptoms of organ dysfunctions, absence of an alternative diagnosis, and history of COVID-19 infection or exposure with possible cardiac and neurological presentations ( There are similarities between MIS-C and atypical Kawasaki disease
12% of participants continued losing weight through week 48 without reaching plateau 8% of participants experienced early plateau before week 36, then maintained successfully 80% of participants reached plateau between weeks 36-48 as expected The plateau phase shows Retatrutides maintenance value
This is a known side effect that can vary in intensity among individuals
SalimHMFukudaDHigashikuniYTanakaKHirataYYagiSet al